+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nephrostomy Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805763
The value of global nephrostomy devices market was USD 1.25 billion in 2022, driven by the increasing prevalence of urological disorders and the growing aging population across the globe. The market size is anticipated to grow at a CAGR of 8.5% during the forecast period of 2023-2031 to achieve a value of USD 2.61 billion by 2031.

Nephrostomy Devices: Introduction

Nephrostomy is a medical procedure that involves the placement of a tube called a nephrostomy tube into the kidney to drain urine and relieve urinary tract obstructions. Nephrostomy devices are specifically designed tools and accessories used in the nephrostomy procedure to ensure proper placement and functioning of the nephrostomy tube. These devices play a crucial role in maintaining renal function and providing relief to patients with urinary tract obstructions.

Key Trends in the Nephrostomy Devices Market

Some key trends involved in the nephrostomy devices market are as follows:
  • Technological Advancements: The nephrostomy devices market is witnessing continuous technological advancements. Innovations such as the development of minimally invasive procedures, image-guided techniques, and improved catheter materials have improved the accuracy and effectiveness of nephrostomy procedures. These advancements aim to enhance patient comfort, reduce complications, and improve overall treatment outcomes
  • Increasing Prevalence of Urological Disorders: Urological disorders such as kidney stones, urinary tract obstructions, and cancer are on the rise globally. As a result, there is a growing demand for nephrostomy procedures and devices. The increasing prevalence of these disorders is a significant driver for the nephrostomy devices market, as it necessitates the use of these devices for effective management and treatment
  • Growing Aging Population: The aging population is more prone to urological disorders and kidney-related issues, leading to an increased demand for nephrostomy procedures. The rising geriatric population, especially in developed countries, is a key demographic factor driving the demand for nephrostomy devices. As the elderly population continues to grow, the need for nephrostomy procedures and devices is expected to rise correspondingly
  • Rising Preference for Minimally Invasive Procedures: Minimally invasive procedures are gaining popularity in the field of urology and nephrology due to their benefits such as reduced trauma, faster recovery, and shorter hospital stays. Nephrostomy procedures, including percutaneous nephrostomy, are less invasive compared to traditional open surgeries, and this trend is driving the adoption of nephrostomy devices that support minimally invasive techniques

Nephrostomy Devices Market Segmentations

Market Breakup by Product Type

  • Guidewires
  • Drainage Tubes
  • Nephrostomy Catheters
  • Sheath Dilators
  • Others

Market Breakup by End User

  • Hospitals
  • Emergency Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Nephrostomy Devices Market Scenario

The global nephrostomy devices market is witnessing significant growth due to the increasing prevalence of urological disorders and the growing aging population. Nephrostomy devices play a crucial role in the management and treatment of urinary tract obstructions, kidney stones, and other kidney-related issues. These devices ensure proper placement and functioning of nephrostomy tubes, allowing for effective drainage of urine and relief of obstructions.

Technological advancements in nephrostomy procedures and devices have led to improved accuracy, safety, and patient comfort. Minimally invasive techniques, image-guided procedures, and advanced catheter materials have revolutionized the field of nephrostomy, making it a preferred choice for patients and healthcare providers. The rising preference for minimally invasive procedures is driving the demand for nephrostomy devices that support these techniques.

The increasing healthcare expenditure in both developed and developing countries is also contributing to market growth. The availability of advanced medical technologies and increased access to healthcare services are driving the adoption of nephrostomy procedures and devices. Moreover, the growing aging population, particularly in developed countries, is fuelling the demand for nephrostomy devices as elderly individuals are more susceptible to urological disorders.

Nephrostomy Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Cook Medical Incorporated
  • B. Braun Melsungen AG
  • Sungen AG
  • Argon Medical
  • Cardinal Health
  • Straub Medical AG
  • Olympus Corporation
  • Coloplast

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nephrostomy Devices Market Overview
3.1 Global Nephrostomy Devices Market Historical Value (2016-2022)
3.2 Global Nephrostomy Devices Market Forecast Value (2023-2031)
4 Global Nephrostomy Devices Market Landscape
4.1 Global Nephrostomy Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nephrostomy Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Major Regions
5 Global Nephrostomy Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nephrostomy Devices Market Segmentation
6.1 Global Nephrostomy Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Guidewires
6.1.3 Drainage Tubes
6.1.4 Nephrostomy Catheters
6.1.5 Sheath Dilators
6.1.6 Others
6.2 Global Nephrostomy Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Emergency Clinics
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Global Nephrostomy Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Nephrostomy Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nephrostomy Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nephrostomy Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nephrostomy Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nephrostomy Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Teleflex Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Cook Medical Incorporated
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun Melsungen AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Sungen AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Argon Medical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cardinal Health
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Straub Medical AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Olympus Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Coloplast
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Nephrostomy Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Cook Medical Incorporated
  • B. Braun Melsungen AG
  • Sungen AG
  • Argon Medical
  • Cardinal Health
  • Straub Medical AG
  • Olympus Corporation
  • Coloplast

Methodology

Loading
LOADING...

Table Information